Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Quipt Home Medical Corp V.QIPT


Primary Symbol: T.QIPT Alternate Symbol(s):  QIPT

Quipt Home Medical Corp. is a home medical equipment provider. The Company specializes in improving the home management of chronic illness through the application of telehealth systems and automated distribution. It provides in-home monitoring and disease management services, including end-to-end respiratory solutions for patients in the United States. It offers nebulizers, oxygen concentrators, continuous positive airway pressure (CPAP) and Bilevel Positive Airway Pressure (BiPAP) units; traditional and non-traditional medical respiratory equipment and services, and non-invasive ventilation equipment, supplies, and services. The Company's product offerings include the management of several chronic disease states focusing on patients with heart or pulmonary disease, sleep disorders, reduced mobility, and other chronic health conditions. Its products and services consist of sleep apnea and pap treatment, home ventilation, daily and ambulatory aides, and respiratory equipment rental.


TSX:QIPT - Post by User

Bullboard Posts
Comment by TallerCraigon Jul 30, 2018 4:18am
288 Views
Post# 28383884

RE:RE:My Q3 Preview: Sequential Rev & EBITDA growth at 2.5x EBITDA

RE:RE:My Q3 Preview: Sequential Rev & EBITDA growth at 2.5x EBITDAFair point. Multiple expansion will come with EBITDA margin expansion and they can prove Bad Debt can stay in the 8-12% range. If private smaller players in the space they would be looking to acquire are getting valuations to the point PHM.V passes on acquiring them the base assumption for current PHM.V valuation is too low. HIGHER.
Bullboard Posts